trial · primary record
Bemnifosbuvir-Ruzasvir (BEM/RZR)
HEPATITIS C VIRUS CHRONIC INFECTION
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 940 |
| Primary completion | 2026-09-09 |
| Primary endpoint | Proportion of subjects achieving HCV RNA less than the lower limit of quantitation (LLOQ) at study week 24. |
| Registry ID | NCT06868264 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:27.827Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06868264
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.